Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Sutro Biopharma Inc
Swot
Sutro Biopharma Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Sutro Biopharma Inc has 8 Strengths, 10 Weaknesses, 0 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(8)
Weakness
(10)
Opportunity
(0)
Threats
(2)
Others
(1)
Relative Outperformance versus Industry over the Quarter (3 Months)
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Increasing Revenue every quarter for the past 2 quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Top Gainers
Stock with Low PE (PE < = 10)
Stocks Outperforming their Industry Price Change in the Quarter
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Oversold by Money Flow Index (MFI)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Highest fall from 52 Week High
Low Piotroski Score : Companies with weak financials
Book Value Per Share deteriorating for last 2 years
Declining profits every quarter for the past 3 quarters
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter
Promoters increasing shareholding QoQ
